Author

D. Weiser

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Approach:genetic perturbation / CRISPR· 1 Organism:human· 1 Assay:multiome· 1

Frequent Co-Authors

A. Ansary· 1 shared C. Awah· 1 shared F. Dong· 1 shared F. Levine· 1 shared J. Zhang· 1 shared K. Yang· 1 shared L. Ash· 1 shared O. O. Ogunwobi· 1 shared

Activity by Year

2022-2022 · peak 1/yr

Co-Author Collaboration Network

9 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Ansary

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Destabilized 3UTR ARE therapeutically degrades ERBB2 in drug-resistant ERBB2+ cancer models

C. Awah, Y. Glemaud, F. Levine, K. Yang, A. Ansary, F. Dong, L. Ash, J. Zhang, D. Weiser, O. O. Ogunwobi

The paper develops a method to degrade ERBB2 mRNA and protein by destabilizing its 3UTR AU-rich elements, showing efficacy in drug-resistant cancer models.

bioRxiv · Aug 14, 2022 · PreprintCancer Biology